Medtech makers RyMed Technologies and Medical Action Industries are teaming up to distribute IV therapy devices to more hospitals.
RyMed Technologies Inc.
A patent spat between St. Jude Medical (NYSE:STJ) and Occlutech GmbH that morphed into a personal lawsuit against Occlutech CEO Tor Peters was dismissed by a German court, prompting Peters to call the suit "amazing and quite shocking."
St. Jude inherited the case, involving intravascular occlusion devices, after it acquired AGA Medical for more than $1 billion last year.
UPDATED Dec. 22, 12:35 p.m.
ICU Medical Inc. (NSDQ:ICUI) landed a patent victory over RyMed Technologies Inc.
An eight-person jury in the U.S. District Court for Delaware found that technology employed in Franklin, Tenn.-based RyMed’s InVision Plus IV connector infringes upon two patents owned by ICU Medical.